Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 4Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 6

Sponsor

Cancer Type

Lymphoid 3Gynecologic 1Breast 1

Conditions

Lymphoma, Follicular 3Hypertension 3Triple Negative Breast Neoplasms 1Polycystic Ovary Syndrome 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Amlodipine × Clear all
NCT06236061 2026-01-13

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Novartis

Phase 3 Completed
718 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

NCT06942377 2025-07-08

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

Peking University People's Hospital

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Endometrial Neoplasms

NCT02834403 2023-12-15

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

The Methodist Hospital Research Institute

Phase 1/2 Completed
37 enrolled 20 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02544776 2016-03-25

Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

Ain Shams Maternity Hospital

Phase NA Completed
60 enrolled

Polycystic Ovary Syndrome

NCT02072330 2014-02-26

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Takeda

Phase 2/3 Completed
353 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

NCT01048047 2010-01-13

Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients

University of Pavia

Phase 4 Unknown
88 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡